Joanne Rossman, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Dr. Joanne Rossman graduated the medical school from Medical College of Georgia School of Medicine and completed both her residency and fellowship program at the University of Alabama Medical Center. She is specialized in Medical Oncology and board certified in Hematology and Medical Oncology. Dr. Rossman has been in practice for more than 11 years and is affiliated with the Princeton Baptist Medical Center. During her career, she has also contributed to two publications of medical interest.
Medical College of Georgia
Medical School
University of Alabama Medical Center
Internship
University of Alabama Medical Center
Residency
University of Alabama Medical Center
Fellowship
American Board of Internal Medicine - Oncology
Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemother...
Rossman, J.,Reddy, V.,Cantor, A.,Miley, D.,Robert, F.; Lung Cancer. 2010 Oct 12.
See more >>Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.
Rossman, J.F., Falkson, C.I., Xu, R., Slabber, C.F., Mason, B.A., Mulcahy, M.F., Benson, A.B.; Gastrointest Cancer Res. 2011 Jan.
See more >>American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
Eastern Cooperative Oncology Group